Filing Details

Accession Number:
0000905718-19-000596
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-11 16:43:19
Reporting Period:
2019-07-09
Accepted Time:
2019-07-11 16:43:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130598 Onconova Therapeutics Inc. ONTX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219314 P L Partners Capital Tyndall 150 East 58Th Street
14Th Floor
New York NY 10155
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-07-09 8,185 $2.84 805,249 No 4 S Indirect See Note
Common Stock Disposition 2019-07-10 2,742 $2.81 802,507 No 4 S Indirect See Note
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Note
No 4 S Indirect See Note
Footnotes
  1. Tyndall Capital Partners, L.P. ("Tyndall Capital") is the general partner of Tyndall Partners, L.P. ("Tyndall"), and possesses the sole power to vote and the sole power to direct the disposition of all securities held by Tyndall. Tyndall Capital's interest in the securities reported herein is limited to the extent of its pecuniary interest in such securities, if any.